Bulletin
Investor Alert

New York Markets Open in:

Intercept Pharmaceuticals Inc.

NAS: ICPT

GO
/marketstate/country/us

After Hours

 --Real time quotes

May 24, 2022, 7:03 p.m.

/zigman2/quotes/202434567/composite

$

16.83

Change

+0.21 +1.26%

Volume

Volume 27,940

Real time quotes

/zigman2/quotes/202434567/composite

Previous close

$ 17.98

$ 16.62

Change

-1.36 -7.56%

Day low

Day high

$16.53

$17.83

Open

52 week low

52 week high

$11.60

$22.36

Open

Insider Actions for Intercept Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/15/2022 Linda M. Richardson
EVP & Chief Commercial Officer
124   Derivative/Non-derivative trans. at $17.88 per share. 2,217
05/01/2022 Jared M. Freedberg
General Counsel
771   Derivative/Non-derivative trans. at $15.71 per share. 12,112
04/11/2022 Bryan Ball
Chief Qual. Officer & SVP Ops.
531   Derivative/Non-derivative trans. at $17.19 per share. 9,127
02/15/2022 Linda M. Richardson
EVP & Chief Commercial Officer
171   Derivative/Non-derivative trans. at $15.93 per share. 2,724
02/14/2022 Linda M. Richardson
EVP & Chief Commercial Officer
529   Derivative/Non-derivative trans. at $14.85 per share. 7,855
02/12/2022 Gail Cawkwell
SVP, Med Affairs, Safety & PV
320   Derivative/Non-derivative trans. at $15.8 per share. 5,056
02/01/2022 Jared M. Freedberg
General Counsel
4,072   Derivative/Non-derivative trans. at $16.91 per share. 68,857
01/27/2022 Jerome B. Durso
President & CEO; Director
35,700   Award at $0 per share. 0
01/27/2022 M. Michelle Berrey
President, R&D and CMO
10,300   Award at $0 per share. 0
01/27/2022 Andrew Saik
EVP & Chief Financial Officer
10,300   Award at $0 per share. 0
01/27/2022 Jared M. Freedberg
General Counsel
10,300   Award at $0 per share. 0
01/27/2022 Gail Cawkwell
SVP, Med Affairs, Safety & PV
6,600   Award at $0 per share. 0
01/27/2022 Linda M. Richardson
EVP & Chief Commercial Officer
10,300   Award at $0 per share. 0
01/27/2022 David Ford
Chief Human Resources Officer
6,600   Award at $0 per share. 0
01/27/2022 Bryan Ball
Chief Qual. Officer & SVP Ops.
3,600   Award at $0 per share. 0
01/27/2022 Rocco Venezia
Chief Accounting Officer
3,600   Award at $0 per share. 0
01/11/2022 Bryan Ball
Chief Qual. Officer & SVP Ops.
2,455   Derivative/Non-derivative trans. at $16.83 per share. 41,317
01/01/2022 Jerome B. Durso
President & CEO; Director
334   Derivative/Non-derivative trans. at $16.29 per share. 5,440
01/01/2022 David Ford
Chief Human Resources Officer
106   Derivative/Non-derivative trans. at $16.29 per share. 1,726
01/01/2022 Rocco Venezia
Chief Accounting Officer
35   Derivative/Non-derivative trans. at $16.29 per share. 570

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
3 Sales
0
1,426
Last 6 months
10 Purchases
18 Sales
103,438
25,201
Last 12 months
24 Purchases
38 Sales
305,224
51,989

Officers and Executives

Mr. Jerome B. Durso
President, Chief Executive Officer & Director
Mr. Bryan Ball
Chief Quality Officer & Senior VP-Operations
Mr. Andrew Saik
Chief Financial Officer
Dr. M. Michelle Berrey
Chief Medical Officer
Dr. Gail Cawkwell
SVP-Medical Affairs, Safety & Pharmacovigilance
Ms. Linda M. Richardson
Chief Commercial Officer & Executive VP
Dr. Mark E. Pruzanski
Director
Mr. Rocco Venezia
Treasurer & Chief Accounting Officer
Mr. David Ford
Chief Human Resources Officer
Mr. Jared M. Freedberg
Secretary & General Counsel
Mr. Paolo Fundarò
Chairman
Ms. Dagmar Rosa-Bjorkeson
Independent Director
Dr. Srinivas Akkaraju
Independent Director
Mr. Glenn P. Sblendorio
Independent Director
Dr. Luca Benatti
Independent Director
Mr. Gino Santini
Lead Independent Director
Mr. Daniel Mark Bradbury
Independent Director
Dr. Keith M. Gottesdiener
Independent Director
Ms. Nancy Miller-Rich
Independent Director
Link to MarketWatch's Slice.